Cargando…

Safety and tolerability of regadenoson CMR

AIMS: Knowledge of adverse events associated with regadenoson perfusion cardiac magnetic resonance (CMR) and patient tolerability has implications for patient safety and staff training. We sought to assess the safety and tolerability of regadenoson stress CMR. MATERIALS AND METHODS: A group of 728 c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Kim-Lien, Bandettini, W. Patricia, Shanbhag, Sujata, Leung, Steve W., Wilson, Joel R., Arai, Andrew E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060784/ https://www.ncbi.nlm.nih.gov/pubmed/24451179 http://dx.doi.org/10.1093/ehjci/jet278

Ejemplares similares

Time resolved measure of coronary sinus flow following regadenoson administration
por: Booker, O Julian, et al.
Publicado: (2011)

Regadenoson stress induced wall motion abnormalities during cardiac MRI
por: Parikh, Kalindi, et al.
Publicado: (2015)

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients
por: Vasu, Sujethra, et al.
Publicado: (2011)

Impaired coronary vasodilation with Regadenoson in patients with angiographically normal coronaries when compared to normal volunteers - Insights from Quantitative MRI Perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

LV wall motion assessment during regadenoson vasodilator stress CMR
por: Jesinger, Michael, et al.
Publicado: (2016)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

Interobserver reproducibility of fully quantitative pixel-wise analysis of clinical CMR perfusion imaging
por: Conn, Hannah, et al.
Publicado: (2014)

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
por: Muñiz-Sáenz-Diez, Javier, et al.
Publicado: (2023)

Diagnostic performance of regadenoson stress CMR for detection of coronary artery disease
por: Patel, Mita, et al.
Publicado: (2015)

MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study
por: Bandettini, W Patricia, et al.
Publicado: (2012)

A comparison of cine CMR imaging at 0.55 T and 1.5 T
por: Bandettini, W. Patricia, et al.
Publicado: (2020)

Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience
por: Kellman, Peter, et al.
Publicado: (2012)

Determinants of myocardial perfusion reserve measured from coronary sinus phase-contrast imaging during regadenoson stress CMR
por: Bauml, Michael A, et al.
Publicado: (2014)

Concordance and diagnostic accuracy of vasodilator stress cardiac MRI and 320-detector row coronary CTA
por: Chen, Marcus Y., et al.
Publicado: (2013)

Characterization of cardiac masses with T1 mapping
por: Saba, Shahryar G, et al.
Publicado: (2015)

Heterogeneity of resting and hyperemic myocardial blood flow in healthy volunteers: a quantitative CMR perfusion pixel-map study
por: Greve, Anders M, et al.
Publicado: (2014)

Clinical impact of cardiovascular magnetic resonance in evaluation for possible arrhythmogenic right ventricular dysplasia/cardiomyopathy
por: Choi, Andrew D, et al.
Publicado: (2015)

Safety and tolerability of intravenous regadenoson in healthy subjects: A randomized, repeat-dose, placebo-controlled study
por: Townsend, Robert, et al.
Publicado: (2015)

High prevalence of atypical delayed enhancement in alkaptonuria
por: Chen, Marcus Y, et al.
Publicado: (2014)

Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: a quantitative and kinetic study(†)
por: Hammer-Hansen, Sophia, et al.
Publicado: (2016)

Myocardial extracellular volume imaging by CMR quantitatively characterizes myocardial infarction and subclinical myocardial fibrosis
por: Ugander, Martin, et al.
Publicado: (2011)

Safety, tolerability and feasibility of adenosine stress CMR in high-risk patients
por: Dastidar, Amardeep Ghosh, et al.
Publicado: (2015)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Clinical Images: Cardiovascular magnetic resonance to detect and monitor inflammatory myocarditis in systemic lupus erythematosus
por: Pamuk, Omer N., et al.
Publicado: (2021)

Regadenoson in the detection of coronary artery disease
por: Buhr, Christiane, et al.
Publicado: (2008)

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing
por: Minor, Matthew, et al.
Publicado: (2015)

Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023)

A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease
por: Prenner, Bruce M., et al.
Publicado: (2012)

Image quality and diagnostic accuracy of inline motion-corrected (moco) first-pass stress myocardial perfusion images
por: Shanbhag, Sujata M, et al.
Publicado: (2011)

Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients
por: Kazmirczak, Felipe, et al.
Publicado: (2019)

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease
por: Ananthasubramaniam, Karthik, et al.
Publicado: (2012)

Fully quantitative pixel-wise analysis of cardiovascular magnetic resonance perfusion improves discrimination of dark rim artifact from perfusion defects associated with epicardial coronary stenosis
por: Ta, Allison D., et al.
Publicado: (2018)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow
por: Patel, Shivani G., et al.
Publicado: (2022)

Hemodynamic and Respiratory Effects of Regadenoson During Radiologic Imaging in Infants and Children
por: Schloss, Brian, et al.
Publicado: (2021)

In the absence of obstructive coronary artery disease, patients with class II and III obesity have decreased myocardial perfusion reserve
por: Bandettini, W Patricia, et al.
Publicado: (2014)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hh5g46r2si92o6gfj1foqb7sbd